3 completed, 2 recruiting, 1 unknown. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Recruiting 2, Unknown 1 |
Follow EBV: new trials by email Literature Review of EBV trials Research Report on EBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults VXCO-102, Placebo - EBV | Phase 1 | Recruiting | Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company | 82 | 2026-11-16 | 2026-10-26 |
| Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection EBV gp350-ferritin vaccine with ALFQ adjuvant, EBV gH/gL/gp42-ferritin nanoparticle vaccine with ALFQ adjuvant - EBV, Epstein-Barr Virus Infection | Phase 1 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 750 | 2025-05-29 | 2026-10-26 |
| Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults EBV gp350-Ferritin Vaccine - EBV, Epstein-Barr Virus Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 83 | 2022-03-29 | 2026-08-13 |
| Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) CTL for CMV seropositive donors, CTL for CMV naïve donors - EBV, CMV | Phase 1 | Completed | Catherine Bollard | 27 | 2014-02-01 | 2025-07-03 |
| Cytotoxic T Cells to Prevent Virus Infections Cytotoxic T lymphocytes (CTLs). - CMV, EBV | Phase 1 | Completed | Children's National Research Institute | 10 | 2013-09-01 | 2020-07-14 |
| Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation Virus specific CTLs - CMV Infection, EBV | Phase 1 | Unknown | University of Sydney | 25 | 2013-01-01 | 2016-07-21 |
Adenoviridae Infections (3) · Epstein-Barr Virus Infections (3) · Infectious Mononucleosis (2) · Cytomegalovirus Infections (1)
DNA Virus Infections (6) · Infections (6) · Virus Diseases (6) · Herpesviridae Infections (4) · Tumor Virus Infections (3) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukocyte Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · Catherine Bollard (1) · Children's National Research Institute (1) · University of Sydney (1) · Vaccine Company, Inc, a wholly owned subsidiary of Eli Lilly and Company (1)
United States (4) · Australia (2)
Jessica R Durkee-Shock, M.D. (2) · Catherine Bollard, MD (1) · Catherine M Bollard, M.D (1)